We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+21.69%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$150M
AUM Growth
+$13M
Cap. Flow
-$2.13M
Cap. Flow %
-1.42%
Top 10 Hldgs %
33.6%
Holding
92
New
24
Increased
18
Reduced
19
Closed
31

Top Buys

Rank Stock Value
1
MLM icon
Martin Marietta Materials
MLM
+$3.6M
2
ICLR icon
Icon
ICLR
+$3.13M
3
EW icon
Edwards Lifesciences
EW
+$3.1M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$3.06M
5
TWTR
Twitter, Inc.
TWTR
+$2.75M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.76M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$2.87M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.47M
4
AGN
Allergan Inc
AGN
+$2.4M
5
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$2.18M

Sector Composition

Rank Sector Weight
1 Healthcare 40.29%
2 Industrials 15.71%
3 Communication Services 12.16%
4 Consumer Discretionary 11.17%
5 Materials 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABMD
26
DELISTED
Abiomed Inc
ABMD
$2.58M 1.72%
+36,000
New +$1.95M
ESPR
27
DELISTED
Esperion Therapeutics
ESPR
$2.55M 1.7%
+27,500
New +$1.77M
UTHR icon
28
United Therapeutics
UTHR
$25.7B
$2.41M 1.61%
+14,000
New +$2.13M
TEVA icon
29
Teva Pharmaceuticals
TEVA
$40.2B
$2.37M 1.58%
+38,000
New +$2.21M
JAZZ icon
30
Jazz Pharmaceuticals
JAZZ
$15.8B
$2.35M 1.57%
13,600
+6,500
+92% +$1.12M
BLUE
31
DELISTED
bluebird bio
BLUE
$2.17M 1.45%
1,390
-115
-8% -$152K
ACHC icon
32
Acadia Healthcare
ACHC
$2.85B
$2.15M 1.43%
30,000
+2,000
+7% +$128K
CSTE icon
33
Caesarstone
CSTE
$75.4M
$2.13M 1.42%
35,000
-20,350
-37% -$1.25M
NBIX icon
34
Neurocrine Biosciences
NBIX
$16.7B
$2.03M 1.36%
51,200
+36,200
+241% +$1.29M
ALLE icon
35
Allegion
ALLE
$13.7B
$1.96M 1.31%
+32,000
New +$1.83M
DIS icon
36
Walt Disney
DIS
$170B
$1.89M 1.26%
18,000
-4,000
-18% -$404K
HUM icon
37
Humana
HUM
$45B
$1.87M 1.25%
10,500
-2,400
-19% -$380K
INCY icon
38
Incyte
INCY
$24B
$1.83M 1.22%
20,000
+11,500
+135% +$951K
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
$1.82M 1.21%
+24,500
New +$1.73M
CELG
40
DELISTED
Celgene Corp
CELG
$1.79M 1.19%
15,500
-6,000
-28% -$717K
FOLD
41
DELISTED
Amicus Therapeutics
FOLD
$1.77M 1.18%
163,000
-37,000
-19% -$326K
UHS icon
42
Universal Health Services
UHS
$10.2B
$1.71M 1.14%
14,500
-13,160
-48% -$1.46M
RDUS
43
DELISTED
Radius Health, Inc.
RDUS
$1.67M 1.11%
40,500
+7,500
+23% +$337K
GME icon
44
PUT
GameStop
GME
$8.55B
$1.66M 1.11%
+175,200
New +$1.65M
SCTY
45
DELISTED
SolarCity Corporation
SCTY
$1.54M 1.03%
+30,000
New +$1.54M
ADPT
46
DELISTED
Adeptus Health Inc
ADPT
$1.46M 0.97%
29,000
+1,000
+4% +$39.6K
CPAY icon
47
Corpay
CPAY
$25.2B
$1.28M 0.86%
8,500
+500
+6% +$74K
HAPN
48
Happen Inc
HAPN
$2.36B
$1.28M 0.85%
13,000
-10,000
-43% -$1.04M
TRUE
49
DELISTED
TrueCar
TRUE
$1.21M 0.81%
68,000
-29,000
-30% -$541K
BHC icon
50
Bausch Health
BHC
$2.62B
$1.19M 0.8%
+6,000
New +$1.06M
1
2
3 4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Atika Capital Management held 92 positions worth $150M, up 9.5% from $137M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management's Q1 2015 filing shows 24 new, 18 increased, 19 reduced and 31 closed positions. Its largest new stake was Martin Marietta Materials: 28,000 shares worth $3.92M. The largest sale was AbbVie, an estimated $3.76M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Industrials and Communication Services.

  • Atika Capital Management's largest Q1 2015 buy was Martin Marietta Materials: 28,000 shares worth $3.92M.
  • Atika Capital Management added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q1 2015, an estimated $1.63M increase.
  • Atika Capital Management's biggest Q1 2015 reduction was Acadia Pharmaceuticals, cutting an estimated $2.87M.
  • Atika Capital Management fully exited AbbVie in Q1 2015, selling an estimated $3.76M.
  • Atika Capital Management's ten largest holdings make up 34% of its $150M portfolio in Q1 2015.
  • Atika Capital Management opened 24 new positions and closed 31 in Q1 2015.
  • Atika Capital Management's portfolio value rose 9.5% quarter-over-quarter to $150M.

Based on Atika Capital Management's 13F filing for Q1 2015, filed 15 May 2015.